semaglutide vs. tirzepatide which glp-1 is right for you Not sure whether or you? π€β¨ Both are powerful medical weight loss optionsβbut the best choice depends on your goals, history, and how your body responds. π Peptide Monday: Semaglutide vs Tirzepatide
Description
A wave of 2nd generation GLP-1 agonists came to market between 2014-2021, improving clinical outcomes and providing more convenient dosing and administration options
this period was chosen because the reimbursement for GLP-1RAs in Taiwans NHI program began in 2011
BMI, body mass index

The gradual titration protocol exists specifically to manage this

Credit/Source: Maryam Daneshpour #biosimiliar #biotech #biopharma #pharmaceuticals To view or add a comment, sign in Biosimilars: FDA vs EMA Approvals Big news in biosimilars: the FDA has, for the first time, accepted a monoclonal antibody (mAb) biosimilar application without requiring clinical efficacy studies
